Ten-year outcomes of surgical treatment of ischemic mitral regurgitation-a retrospective study
Keywords:IMR, Coronary surgery, CABG, Mitral valve repair, Mitral valve replacement, Long-term outcomes
Background: Mitral regurgitation (MR) is a prevalent form of valvular heart disease, affecting millions of people worldwide. Primary MR occurs due to mitral valve dysfunction, while secondary MR is caused by left ventricle remodelling. The study aimed to investigate the long-term outcomes of patients with IMR after undergoing coronary surgeries, including coronary artery bypass graft (CABG) with or without mitral valve repair or replacement.
Methods: Retrospective, observational study design was planned. Pre-operative and postoperative data were collected from 68 patients with ischemic MR who underwent coronary artery bypass surgery, with or without Mitral valve replacement or mitral valve repair. (That is CABG only/CABG+MVR/CABG+MVr) in the year between 2001 and 2010. Patients followed up at 3 months, 1 year, and 10 years after the procedure.
Results: Significant improvements in New York heart association (NYHA) functional class and MR status were observed for all three surgical groups, namely, a) CABG surgery, b) coronary artery bypass graft surgery with mitral valve replacement (CABG+MVR), and c) coronary artery bypass graft surgery with mitral valve repair (CABG+MVr). After 10 years, redo surgery rates were minimal for CABG only and CABG+MVR groups of patients, while CABG+MVr required 20% redo surgery. Postoperative complications, such as left ventricle failure, were seen in the immediate postoperative period, leading to the death of those patients 3 months following the surgery. After 3 months, complications decreased over time for all groups.
Conclusions: Surgical interventions effectively improved functional outcomes and reduced MR severity in patients with ischemic MR. Redo surgery rates were low for most patients, indicating the success of the initial procedures.
Nonaka DF, Fox AA. Ischemic mitral regurgitation: Repair, replacement or nothing. Semin Cardiothorac Vasc Anesth. 2019;23(1):11-9.
Kron IL, LaPar DJ, Acker MA, Adams DH, Ailawadi G, Bolling SF, et al. 2016 Update to The American Association for Thoracic Surgery (AATS) consensus guidelines: Ischemic mitral valve regurgitation. J Thorac Cardiovasc Surg. 2017;153(5):e97-114.
Aluru JS, Barsouk A, Saginala K, Rawla P, Barsouk A. Valvular heart disease epidemiology. Med Sci (Basel). 2022;10(2):32.
Roth GA, Mensah GA, Fuster V. The global burden of cardiovascular diseases and risks. J Am Coll Cardiol 2020;76(25):2980-1.
Smith PK, Puskas JD, Ascheim DD, Voisine P, Gelijns AC, Moskowitz AJ, et al. Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med. 2014;371(23):2178-88.
El-Bardissi AW, Aranki SF, Sheng S, O'Brien SM, Greenberg CC, Gammie JS. Trends in isolated coronary artery bypass grafting: An analysis of the Society of Thoracic Surgeons adult cardiac surgery database. J Thorac Cardiovasc Surg. 2012;143(2):273-81.
Wang W, Li B, Wang Y, Piao H, Zhu Z, Xu R, et al. Experience of the management of coronary artery bypass graft only on moderate ischemic mitral regurgitation: A single-centre retrospective study. Medicine (Baltimore). 2019;98(17):e14969.
Kang D-H, Kim M-J, Kang S-J, Song J-M, Song H, Hong M-K, et al. Mitral valve repair versus revascularization alone in the treatment of ischemic mitral regurgitation. Circulation. 2006;114(4):I499-503.
Avierinos J-F, Detaint D, Messika-Zeitoun D, Mohty D, Enriquez-Sarano M. Risk, determinants, and outcome implications of progression of mitral regurgitation after diagnosis of mitral valve prolapse in a single community. Am J Cardiol. 2008;101(5):662-7.
Dziadzko V, Clavel M-A, Dziadzko M, Medina-Inojosa JR, Michelena H, Maalouf J, et al. Outcome and undertreatment of mitral regurgitation: a community cohort study. Lancet 2018;391(10124):960-9.
Chow SCY, Wong RHL, Cheung GSH, Lee APW, Chui HKL, So KCY, et al. Short-term clinical outcomes and analysis of risk factors for pacemaker implantation: a single center experience of self-expandable TAVI valves. J Cardiothorac Surg. 2020;15(1):200.
Koene RJ, Norby FL, Maheshwari A, Rooney MR, Soliman EZ, Alonso A, et al. Predictors of sudden cardiac death in atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study. PLoS One 2017;12(11):e0187659.